Mike Polark
Stock Analyst at Wolfe Research
(3.13)
# 1,186
Out of 4,944 analysts
75
Total ratings
45.83%
Success rate
2.31%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Peer Perform | n/a | $92.91 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $15.10 | +32.45% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $53.06 | +13.08% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $308.68 | +13.39% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $87.36 | +170.15% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $166.86 | -10.10% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $15.89 | +82.50% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $77.68 | -22.76% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $288.28 | -37.56% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $103.22 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $378.95 | +6.87% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $482.35 | +4.28% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $129.40 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $122.92 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $79.96 | +51.33% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.13 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $15.72 | +59.03% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $155.97 | +5.79% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $102.50 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.32 | +39.48% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $6.35 | +230.71% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $247.07 | +1.19% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.20 | +3,483.33% | 1 | Sep 2, 2020 |
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $92.91
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $15.10
Upside: +32.45%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $53.06
Upside: +13.08%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $308.68
Upside: +13.39%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $87.36
Upside: +170.15%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $166.86
Upside: -10.10%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $15.89
Upside: +82.50%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $77.68
Upside: -22.76%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $288.28
Upside: -37.56%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $103.22
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $378.95
Upside: +6.87%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $482.35
Upside: +4.28%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $129.40
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $122.92
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $79.96
Upside: +51.33%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.13
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $15.72
Upside: +59.03%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $155.97
Upside: +5.79%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $102.50
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $9.32
Upside: +39.48%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $6.35
Upside: +230.71%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $247.07
Upside: +1.19%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.20
Upside: +3,483.33%